Boostrix Approval History

• FDA approved: Yes (First approved May 3rd, 2005)
• Brand name: Boostrix
• Generic name: tetanus, diphtheria, acellular pertussis vaccine (Tdap)
• Company: GlaxoSmithKline Biologicals
• Treatment for: Diphtheria Prophylaxis, Pertussis Prophylaxis, Tetanus Prophylaxis

Boostrix is a combination vaccine that provides a booster immunization against pertussis (whooping cough) in combination with tetanus and diphtheria.

FDA Approval History for Boostrix

Date	Article
Jul 11, 2011	FDA approves Boostrix to prevent tetanus, diphtheria, and pertussis in older people
Dec 13, 2008	FDA Approves GlaxoSmithKline Tetanus, Diphtheria, Whooping Cough Vaccine, Boostrix, for Adults
May  3, 2005	Boostrix GlaxoSmithKline Biologicals - Treatment for Prevention of Diphtheria, Tetanus & Pertussis in Adolescents
Mar 15, 2005	GlaxoSmithKline Receives Unanimous Favorable Recommendation by FDA Advisory Committee for Boostrix
Jul  7, 2004	GlaxoSmithKline Submits Biologics License Application for FDA Approval of Boostrix

See also...

Boostrix (tetanus, diphtheria, acellular pertussis vaccine (Tdap)) Consumer Information

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.